nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—hypertension—obesity	0.401	1	CtDrD
Penbutolol—HTR1B—obesity	0.109	0.38	CbGaD
Penbutolol—ADRB1—obesity	0.096	0.336	CbGaD
Penbutolol—ADRB2—obesity	0.0808	0.283	CbGaD
Penbutolol—ORM1—Bupropion—obesity	0.0747	0.352	CbGbCtD
Penbutolol—ADRB2—Phenylpropanolamine—obesity	0.0693	0.327	CbGbCtD
Penbutolol—ADRB1—Phenylpropanolamine—obesity	0.0682	0.322	CbGbCtD
Penbutolol—Alopecia reversible—Cimetidine—obesity	0.00448	0.0923	CcSEcCtD
Penbutolol—Short-term memory loss—Sibutramine—obesity	0.00331	0.0682	CcSEcCtD
Penbutolol—ORM1—bile—obesity	0.00195	0.414	CbGeAlD
Penbutolol—Atrioventricular block—Cimetidine—obesity	0.00105	0.0216	CcSEcCtD
Penbutolol—Erectile dysfunction—Methamphetamine—obesity	0.000988	0.0203	CcSEcCtD
Penbutolol—Sweating—Benzphetamine—obesity	0.000885	0.0182	CcSEcCtD
Penbutolol—Disorientation—Cimetidine—obesity	0.000825	0.017	CcSEcCtD
Penbutolol—Sweating—Phendimetrazine—obesity	0.000806	0.0166	CcSEcCtD
Penbutolol—Erectile dysfunction—Phentermine—obesity	0.00071	0.0146	CcSEcCtD
Penbutolol—Rash erythematous—Bupropion—obesity	0.000619	0.0127	CcSEcCtD
Penbutolol—Erectile dysfunction—Diethylpropion—obesity	0.000618	0.0127	CcSEcCtD
Penbutolol—Erectile dysfunction—Cimetidine—obesity	0.000588	0.0121	CcSEcCtD
Penbutolol—Hyperhidrosis—Benzphetamine—obesity	0.000569	0.0117	CcSEcCtD
Penbutolol—Agranulocytosis—Diethylpropion—obesity	0.000558	0.0115	CcSEcCtD
Penbutolol—Insomnia—Methamphetamine—obesity	0.000552	0.0114	CcSEcCtD
Penbutolol—ORM1—gall bladder—obesity	0.000542	0.115	CbGeAlD
Penbutolol—Dyspepsia—Methamphetamine—obesity	0.000537	0.0111	CcSEcCtD
Penbutolol—Insomnia—Benzphetamine—obesity	0.000532	0.011	CcSEcCtD
Penbutolol—Agranulocytosis—Cimetidine—obesity	0.000531	0.0109	CcSEcCtD
Penbutolol—Bradycardia—Cimetidine—obesity	0.00052	0.0107	CcSEcCtD
Penbutolol—Hyperhidrosis—Phendimetrazine—obesity	0.000519	0.0107	CcSEcCtD
Penbutolol—Dyspepsia—Benzphetamine—obesity	0.000518	0.0107	CcSEcCtD
Penbutolol—Insomnia—Phendimetrazine—obesity	0.000485	0.00999	CcSEcCtD
Penbutolol—Alopecia—Diethylpropion—obesity	0.000474	0.00977	CcSEcCtD
Penbutolol—Alopecia—Cimetidine—obesity	0.000451	0.00929	CcSEcCtD
Penbutolol—Amnesia—Sibutramine—obesity	0.00042	0.00865	CcSEcCtD
Penbutolol—Diarrhoea—Methamphetamine—obesity	0.000418	0.0086	CcSEcCtD
Penbutolol—HTR1A—hindbrain—obesity	0.000416	0.0881	CbGeAlD
Penbutolol—Insomnia—Phenylpropanolamine—obesity	0.000414	0.00853	CcSEcCtD
Penbutolol—Dyspnoea—Phenylpropanolamine—obesity	0.000408	0.00841	CcSEcCtD
Penbutolol—Dizziness—Methamphetamine—obesity	0.000404	0.00831	CcSEcCtD
Penbutolol—Diarrhoea—Benzphetamine—obesity	0.000403	0.00829	CcSEcCtD
Penbutolol—Insomnia—Phentermine—obesity	0.000397	0.00816	CcSEcCtD
Penbutolol—Rash erythematous—Topiramate—obesity	0.000394	0.00812	CcSEcCtD
Penbutolol—Dizziness—Benzphetamine—obesity	0.000389	0.00801	CcSEcCtD
Penbutolol—Affect lability—Sibutramine—obesity	0.000388	0.008	CcSEcCtD
Penbutolol—Dyspepsia—Phentermine—obesity	0.000386	0.00795	CcSEcCtD
Penbutolol—Disorientation—Bupropion—obesity	0.000384	0.00792	CcSEcCtD
Penbutolol—Headache—Methamphetamine—obesity	0.000382	0.00787	CcSEcCtD
Penbutolol—Fatigue—Phentermine—obesity	0.000378	0.00778	CcSEcCtD
Penbutolol—Mood swings—Sibutramine—obesity	0.000374	0.00769	CcSEcCtD
Penbutolol—Hyperhidrosis—Diethylpropion—obesity	0.000369	0.00759	CcSEcCtD
Penbutolol—Headache—Benzphetamine—obesity	0.000369	0.00759	CcSEcCtD
Penbutolol—Diarrhoea—Phendimetrazine—obesity	0.000367	0.00756	CcSEcCtD
Penbutolol—Amnesia—Bupropion—obesity	0.000366	0.00754	CcSEcCtD
Penbutolol—Timolol—ADRB3—obesity	0.000363	0.117	CrCbGaD
Penbutolol—Dizziness—Phendimetrazine—obesity	0.000355	0.0073	CcSEcCtD
Penbutolol—Nausea—Benzphetamine—obesity	0.00035	0.0072	CcSEcCtD
Penbutolol—Insomnia—Diethylpropion—obesity	0.000345	0.0071	CcSEcCtD
Penbutolol—Dyspnoea—Diethylpropion—obesity	0.00034	0.007	CcSEcCtD
Penbutolol—Affect lability—Bupropion—obesity	0.000339	0.00697	CcSEcCtD
Penbutolol—Headache—Phendimetrazine—obesity	0.000336	0.00692	CcSEcCtD
Penbutolol—Dyspepsia—Diethylpropion—obesity	0.000336	0.00691	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Orlistat—obesity	0.000327	0.00674	CcSEcCtD
Penbutolol—Mood swings—Bupropion—obesity	0.000326	0.00671	CcSEcCtD
Penbutolol—Nausea—Phendimetrazine—obesity	0.000319	0.00656	CcSEcCtD
Penbutolol—Asthenia—Phentermine—obesity	0.000315	0.00648	CcSEcCtD
Penbutolol—Erectile dysfunction—Sibutramine—obesity	0.000314	0.00647	CcSEcCtD
Penbutolol—Depression—Orlistat—obesity	0.000313	0.00645	CcSEcCtD
Penbutolol—Fatigue—Cimetidine—obesity	0.000313	0.00644	CcSEcCtD
Penbutolol—Atrioventricular block—Topiramate—obesity	0.000311	0.00641	CcSEcCtD
Penbutolol—Depression—Sibutramine—obesity	0.000303	0.00624	CcSEcCtD
Penbutolol—Dizziness—Phenylpropanolamine—obesity	0.000303	0.00624	CcSEcCtD
Penbutolol—Diarrhoea—Phentermine—obesity	0.0003	0.00618	CcSEcCtD
Penbutolol—Sweating—Sibutramine—obesity	0.000291	0.006	CcSEcCtD
Penbutolol—Dizziness—Phentermine—obesity	0.00029	0.00597	CcSEcCtD
Penbutolol—Nadolol—ADRB3—obesity	0.000289	0.0932	CrCbGaD
Penbutolol—Body temperature increased—Cimetidine—obesity	0.000287	0.00591	CcSEcCtD
Penbutolol—Bradycardia—Sibutramine—obesity	0.000278	0.00572	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Bupropion—obesity	0.000276	0.00569	CcSEcCtD
Penbutolol—Bupranolol—ADRB3—obesity	0.000275	0.0889	CrCbGaD
Penbutolol—Headache—Phentermine—obesity	0.000275	0.00566	CcSEcCtD
Penbutolol—Erectile dysfunction—Bupropion—obesity	0.000274	0.00564	CcSEcCtD
Penbutolol—Nausea—Phenylpropanolamine—obesity	0.000272	0.0056	CcSEcCtD
Penbutolol—Diarrhoea—Diethylpropion—obesity	0.000261	0.00537	CcSEcCtD
Penbutolol—Nausea—Phentermine—obesity	0.00026	0.00536	CcSEcCtD
Penbutolol—Asthenia—Cimetidine—obesity	0.00026	0.00536	CcSEcCtD
Penbutolol—Sweating—Bupropion—obesity	0.000254	0.00523	CcSEcCtD
Penbutolol—Dizziness—Diethylpropion—obesity	0.000252	0.00519	CcSEcCtD
Penbutolol—Alopecia—Orlistat—obesity	0.000249	0.00513	CcSEcCtD
Penbutolol—Diarrhoea—Cimetidine—obesity	0.000248	0.00511	CcSEcCtD
Penbutolol—Disorientation—Topiramate—obesity	0.000245	0.00504	CcSEcCtD
Penbutolol—Alopecia—Sibutramine—obesity	0.000241	0.00497	CcSEcCtD
Penbutolol—HTR1B—cardiovascular system—obesity	0.000241	0.0511	CbGeAlD
Penbutolol—Dizziness—Cimetidine—obesity	0.00024	0.00494	CcSEcCtD
Penbutolol—Headache—Diethylpropion—obesity	0.000239	0.00492	CcSEcCtD
Penbutolol—Amnesia—Topiramate—obesity	0.000233	0.0048	CcSEcCtD
Penbutolol—Headache—Cimetidine—obesity	0.000227	0.00468	CcSEcCtD
Penbutolol—ADRB1—cardiovascular system—obesity	0.000227	0.0481	CbGeAlD
Penbutolol—Nausea—Diethylpropion—obesity	0.000227	0.00466	CcSEcCtD
Penbutolol—Affect lability—Topiramate—obesity	0.000216	0.00444	CcSEcCtD
Penbutolol—Nausea—Cimetidine—obesity	0.000216	0.00444	CcSEcCtD
Penbutolol—Cough—Orlistat—obesity	0.000214	0.00441	CcSEcCtD
Penbutolol—Alprenolol—ADRB3—obesity	0.000211	0.0682	CrCbGaD
Penbutolol—Alopecia—Bupropion—obesity	0.00021	0.00433	CcSEcCtD
Penbutolol—Mood swings—Topiramate—obesity	0.000208	0.00427	CcSEcCtD
Penbutolol—Cough—Sibutramine—obesity	0.000207	0.00427	CcSEcCtD
Penbutolol—ADRB1—adipose tissue—obesity	0.0002	0.0424	CbGeAlD
Penbutolol—HTR1A—cardiovascular system—obesity	0.000195	0.0412	CbGeAlD
Penbutolol—Hyperhidrosis—Orlistat—obesity	0.000194	0.00399	CcSEcCtD
Penbutolol—Hyperhidrosis—Sibutramine—obesity	0.000187	0.00386	CcSEcCtD
Penbutolol—Insomnia—Orlistat—obesity	0.000181	0.00373	CcSEcCtD
Penbutolol—Cough—Bupropion—obesity	0.000181	0.00372	CcSEcCtD
Penbutolol—ORM1—endocrine gland—obesity	0.000176	0.0374	CbGeAlD
Penbutolol—Dyspepsia—Orlistat—obesity	0.000176	0.00363	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Topiramate—obesity	0.000176	0.00362	CcSEcCtD
Penbutolol—Insomnia—Sibutramine—obesity	0.000175	0.00361	CcSEcCtD
Penbutolol—Erectile dysfunction—Topiramate—obesity	0.000174	0.00359	CcSEcCtD
Penbutolol—Dyspnoea—Sibutramine—obesity	0.000173	0.00356	CcSEcCtD
Penbutolol—Fatigue—Orlistat—obesity	0.000173	0.00356	CcSEcCtD
Penbutolol—Levobunolol—ADRB1—obesity	0.000172	0.0556	CrCbGaD
Penbutolol—Pain—Orlistat—obesity	0.000171	0.00353	CcSEcCtD
Penbutolol—Dyspepsia—Sibutramine—obesity	0.000171	0.00351	CcSEcCtD
Penbutolol—Depression—Topiramate—obesity	0.000168	0.00347	CcSEcCtD
Penbutolol—Pain—Sibutramine—obesity	0.000166	0.00341	CcSEcCtD
Penbutolol—HTR1B—endocrine gland—obesity	0.000165	0.035	CbGeAlD
Penbutolol—Timolol—ADRB1—obesity	0.000164	0.0531	CrCbGaD
Penbutolol—Hyperhidrosis—Bupropion—obesity	0.000163	0.00336	CcSEcCtD
Penbutolol—ORM1—liver—obesity	0.000159	0.0337	CbGeAlD
Penbutolol—Body temperature increased—Orlistat—obesity	0.000158	0.00326	CcSEcCtD
Penbutolol—Agranulocytosis—Topiramate—obesity	0.000158	0.00324	CcSEcCtD
Penbutolol—ADRB1—endocrine gland—obesity	0.000156	0.033	CbGeAlD
Penbutolol—Bradycardia—Topiramate—obesity	0.000154	0.00318	CcSEcCtD
Penbutolol—HTR1A—adrenal gland—obesity	0.000154	0.0326	CbGeAlD
Penbutolol—Body temperature increased—Sibutramine—obesity	0.000153	0.00316	CcSEcCtD
Penbutolol—Insomnia—Bupropion—obesity	0.000153	0.00315	CcSEcCtD
Penbutolol—Dyspnoea—Bupropion—obesity	0.000151	0.0031	CcSEcCtD
Penbutolol—Dyspepsia—Bupropion—obesity	0.000149	0.00306	CcSEcCtD
Penbutolol—Carteolol—ADRB1—obesity	0.000146	0.0473	CrCbGaD
Penbutolol—Fatigue—Bupropion—obesity	0.000146	0.003	CcSEcCtD
Penbutolol—Levobunolol—ADRB2—obesity	0.000145	0.0468	CrCbGaD
Penbutolol—Pain—Bupropion—obesity	0.000145	0.00298	CcSEcCtD
Penbutolol—Asthenia—Orlistat—obesity	0.000144	0.00296	CcSEcCtD
Penbutolol—Asthenia—Sibutramine—obesity	0.000139	0.00286	CcSEcCtD
Penbutolol—Timolol—ADRB2—obesity	0.000138	0.0446	CrCbGaD
Penbutolol—Diarrhoea—Orlistat—obesity	0.000137	0.00282	CcSEcCtD
Penbutolol—Alopecia—Topiramate—obesity	0.000134	0.00276	CcSEcCtD
Penbutolol—Body temperature increased—Bupropion—obesity	0.000134	0.00275	CcSEcCtD
Penbutolol—HTR1A—endocrine gland—obesity	0.000133	0.0283	CbGeAlD
Penbutolol—Diarrhoea—Sibutramine—obesity	0.000133	0.00273	CcSEcCtD
Penbutolol—Dizziness—Orlistat—obesity	0.000132	0.00273	CcSEcCtD
Penbutolol—Nadolol—ADRB1—obesity	0.000131	0.0421	CrCbGaD
Penbutolol—Dizziness—Sibutramine—obesity	0.000128	0.00264	CcSEcCtD
Penbutolol—Headache—Orlistat—obesity	0.000126	0.00258	CcSEcCtD
Penbutolol—Bupranolol—ADRB1—obesity	0.000125	0.0402	CrCbGaD
Penbutolol—Carteolol—ADRB2—obesity	0.000123	0.0398	CrCbGaD
Penbutolol—Headache—Sibutramine—obesity	0.000121	0.0025	CcSEcCtD
Penbutolol—Asthenia—Bupropion—obesity	0.000121	0.0025	CcSEcCtD
Penbutolol—Nausea—Orlistat—obesity	0.000119	0.00245	CcSEcCtD
Penbutolol—Diarrhoea—Bupropion—obesity	0.000116	0.00238	CcSEcCtD
Penbutolol—Nausea—Sibutramine—obesity	0.000115	0.00237	CcSEcCtD
Penbutolol—Cough—Topiramate—obesity	0.000115	0.00237	CcSEcCtD
Penbutolol—Dizziness—Bupropion—obesity	0.000112	0.0023	CcSEcCtD
Penbutolol—Nadolol—ADRB2—obesity	0.00011	0.0354	CrCbGaD
Penbutolol—Headache—Bupropion—obesity	0.000106	0.00218	CcSEcCtD
Penbutolol—Bupranolol—ADRB2—obesity	0.000105	0.0338	CrCbGaD
Penbutolol—Oxprenolol—ADRB1—obesity	0.000104	0.0337	CrCbGaD
Penbutolol—Hyperhidrosis—Topiramate—obesity	0.000104	0.00214	CcSEcCtD
Penbutolol—Nausea—Bupropion—obesity	0.0001	0.00207	CcSEcCtD
Penbutolol—Propranolol—ADRB3—obesity	9.91e-05	0.032	CrCbGaD
Penbutolol—Insomnia—Topiramate—obesity	9.74e-05	0.00201	CcSEcCtD
Penbutolol—Dyspnoea—Topiramate—obesity	9.6e-05	0.00198	CcSEcCtD
Penbutolol—Alprenolol—ADRB1—obesity	9.55e-05	0.0308	CrCbGaD
Penbutolol—Dyspepsia—Topiramate—obesity	9.48e-05	0.00195	CcSEcCtD
Penbutolol—Fatigue—Topiramate—obesity	9.29e-05	0.00191	CcSEcCtD
Penbutolol—Pain—Topiramate—obesity	9.21e-05	0.0019	CcSEcCtD
Penbutolol—Oxprenolol—ADRB2—obesity	8.78e-05	0.0283	CrCbGaD
Penbutolol—Body temperature increased—Topiramate—obesity	8.51e-05	0.00175	CcSEcCtD
Penbutolol—Alprenolol—ADRB2—obesity	8.03e-05	0.0259	CrCbGaD
Penbutolol—Asthenia—Topiramate—obesity	7.73e-05	0.00159	CcSEcCtD
Penbutolol—Diarrhoea—Topiramate—obesity	7.37e-05	0.00152	CcSEcCtD
Penbutolol—Dizziness—Topiramate—obesity	7.12e-05	0.00147	CcSEcCtD
Penbutolol—Headache—Topiramate—obesity	6.75e-05	0.00139	CcSEcCtD
Penbutolol—Nausea—Topiramate—obesity	6.4e-05	0.00132	CcSEcCtD
Penbutolol—Propranolol—HTR1B—obesity	5.06e-05	0.0163	CrCbGaD
Penbutolol—Propranolol—ADRB1—obesity	4.48e-05	0.0145	CrCbGaD
Penbutolol—Propranolol—ADRB2—obesity	3.77e-05	0.0122	CrCbGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	4.72e-06	0.000104	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT2—obesity	4.7e-06	0.000103	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CB—obesity	4.69e-06	0.000103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—DRD2—obesity	4.69e-06	0.000103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CG—obesity	4.66e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—POMC—obesity	4.64e-06	0.000102	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GCG—obesity	4.64e-06	0.000102	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTPN1—obesity	4.64e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRL—obesity	4.63e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	4.61e-06	0.000101	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STK11—obesity	4.56e-06	0.0001	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL2—obesity	4.54e-06	9.97e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—POMC—obesity	4.54e-06	9.97e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRL—obesity	4.53e-06	9.94e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CD—obesity	4.51e-06	9.92e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PLG—obesity	4.51e-06	9.91e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—RHOA—obesity	4.5e-06	9.89e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STK11—obesity	4.46e-06	9.8e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT2—obesity	4.46e-06	9.8e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	4.45e-06	9.79e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL2—obesity	4.44e-06	9.76e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—POMC—obesity	4.44e-06	9.75e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRL—obesity	4.42e-06	9.72e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PLG—obesity	4.41e-06	9.69e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—RHOA—obesity	4.4e-06	9.67e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PRKCD—obesity	4.4e-06	9.67e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FOXO3—obesity	4.4e-06	9.67e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRB2—obesity	4.39e-06	9.64e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT2—obesity	4.36e-06	9.58e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STK11—obesity	4.36e-06	9.58e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	4.36e-06	9.58e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL2—obesity	4.34e-06	9.54e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SOCS1—obesity	4.32e-06	9.5e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PLG—obesity	4.31e-06	9.48e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HTR2A—obesity	4.31e-06	9.47e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—RHOA—obesity	4.31e-06	9.46e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FOXO3—obesity	4.3e-06	9.46e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—C3—obesity	4.3e-06	9.45e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CD—obesity	4.28e-06	9.41e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SOCS3—obesity	4.27e-06	9.38e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT2—obesity	4.26e-06	9.37e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3R1—obesity	4.26e-06	9.36e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SOCS1—obesity	4.23e-06	9.29e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FOXO3—obesity	4.21e-06	9.25e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRB2—obesity	4.2e-06	9.22e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	4.19e-06	9.21e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GNB3—obesity	4.18e-06	9.18e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SOCS3—obesity	4.18e-06	9.18e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SOCS1—obesity	4.13e-06	9.08e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—TYK2—obesity	4.12e-06	9.06e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	4.11e-06	9.04e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF2—obesity	4.11e-06	9.02e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CD—obesity	4.1e-06	9e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IRS2—obesity	4.09e-06	8.99e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GNB3—obesity	4.09e-06	8.98e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGT—obesity	4.09e-06	8.98e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—RHOA—obesity	4.09e-06	8.98e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SOCS3—obesity	4.08e-06	8.97e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GNAS—obesity	4.07e-06	8.94e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	4.05e-06	8.89e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—TYK2—obesity	4.03e-06	8.86e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	4.02e-06	8.84e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF2—obesity	4.02e-06	8.82e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LEP—obesity	4.01e-06	8.8e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOE—obesity	4.01e-06	8.8e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—RHOA—obesity	4e-06	8.79e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GNB3—obesity	4e-06	8.78e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOB—obesity	3.99e-06	8.76e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GNAS—obesity	3.98e-06	8.75e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CAV1—obesity	3.97e-06	8.72e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOA1—obesity	3.96e-06	8.7e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	3.96e-06	8.7e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—TYK2—obesity	3.94e-06	8.66e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CB—obesity	3.93e-06	8.64e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF2—obesity	3.93e-06	8.63e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—RHOA—obesity	3.91e-06	8.59e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOB—obesity	3.9e-06	8.57e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GNAS—obesity	3.89e-06	8.55e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL5—obesity	3.89e-06	8.55e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3R1—obesity	3.87e-06	8.5e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ESR1—obesity	3.82e-06	8.4e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOB—obesity	3.81e-06	8.38e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL5—obesity	3.81e-06	8.37e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LPL—obesity	3.81e-06	8.36e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FOXO1—obesity	3.78e-06	8.3e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—F2—obesity	3.78e-06	8.3e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PRKCB—obesity	3.78e-06	8.3e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	3.77e-06	8.29e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	3.73e-06	8.2e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—BAD—obesity	3.73e-06	8.2e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL5—obesity	3.72e-06	8.18e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LPL—obesity	3.72e-06	8.18e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FOXO1—obesity	3.7e-06	8.12e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	3.69e-06	8.11e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	3.65e-06	8.03e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LPL—obesity	3.64e-06	8e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CG—obesity	3.61e-06	7.94e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FOXO1—obesity	3.61e-06	7.94e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RPS6KB1—obesity	3.61e-06	7.93e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IRS1—obesity	3.57e-06	7.85e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CB—obesity	3.57e-06	7.85e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCD—obesity	3.51e-06	7.7e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—POMC—obesity	3.44e-06	7.56e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR2A—obesity	3.43e-06	7.54e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCD—obesity	3.43e-06	7.54e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—C3—obesity	3.43e-06	7.53e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—INS—obesity	3.42e-06	7.52e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL2—obesity	3.37e-06	7.4e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR2A—obesity	3.36e-06	7.37e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCD—obesity	3.35e-06	7.37e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—C3—obesity	3.35e-06	7.36e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—obesity	3.31e-06	7.27e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT2—obesity	3.31e-06	7.27e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR2A—obesity	3.28e-06	7.21e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—C3—obesity	3.28e-06	7.2e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IRS2—obesity	3.26e-06	7.16e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGT—obesity	3.26e-06	7.15e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—obesity	3.19e-06	7.01e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOE—obesity	3.19e-06	7.01e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IRS2—obesity	3.19e-06	7.01e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGT—obesity	3.18e-06	7e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CD—obesity	3.18e-06	6.98e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CAV1—obesity	3.16e-06	6.94e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOA1—obesity	3.15e-06	6.93e-05	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3CA—obesity	3.15e-06	6.92e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—obesity	3.14e-06	6.91e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—obesity	3.12e-06	6.86e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOE—obesity	3.12e-06	6.86e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IRS2—obesity	3.12e-06	6.85e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGT—obesity	3.11e-06	6.84e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CAV1—obesity	3.09e-06	6.79e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOA1—obesity	3.08e-06	6.78e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TYK2—obesity	3.06e-06	6.72e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOE—obesity	3.05e-06	6.7e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—obesity	3.05e-06	6.7e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ESR1—obesity	3.05e-06	6.69e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RHOA—obesity	3.03e-06	6.66e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CAV1—obesity	3.02e-06	6.64e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOA1—obesity	3.02e-06	6.63e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCB—obesity	3.01e-06	6.61e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—F2—obesity	3.01e-06	6.61e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOS3—obesity	3e-06	6.59e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3R1—obesity	3e-06	6.59e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ESR1—obesity	2.98e-06	6.55e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—BAD—obesity	2.97e-06	6.53e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—F2—obesity	2.94e-06	6.47e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCB—obesity	2.94e-06	6.47e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ESR1—obesity	2.91e-06	6.4e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—BAD—obesity	2.91e-06	6.39e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CG—obesity	2.88e-06	6.33e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—F2—obesity	2.88e-06	6.32e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCB—obesity	2.88e-06	6.32e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CA—obesity	2.86e-06	6.28e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IRS1—obesity	2.85e-06	6.25e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—BAD—obesity	2.84e-06	6.25e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CG—obesity	2.82e-06	6.19e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IRS1—obesity	2.78e-06	6.12e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CB—obesity	2.77e-06	6.09e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MTOR—obesity	2.77e-06	6.09e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CG—obesity	2.75e-06	6.05e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—POMC—obesity	2.74e-06	6.02e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—INS—obesity	2.72e-06	5.99e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IRS1—obesity	2.72e-06	5.98e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL2—obesity	2.68e-06	5.89e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—POMC—obesity	2.68e-06	5.89e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—INS—obesity	2.67e-06	5.86e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—obesity	2.64e-06	5.79e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT2—obesity	2.63e-06	5.79e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL2—obesity	2.62e-06	5.76e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—POMC—obesity	2.62e-06	5.76e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—INS—obesity	2.61e-06	5.73e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—obesity	2.58e-06	5.67e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT2—obesity	2.58e-06	5.66e-05	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—obesity	2.57e-06	5.65e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL2—obesity	2.56e-06	5.64e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—obesity	2.53e-06	5.56e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CD—obesity	2.53e-06	5.56e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—obesity	2.52e-06	5.54e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT2—obesity	2.52e-06	5.54e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	2.51e-06	5.51e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—obesity	2.5e-06	5.5e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CD—obesity	2.48e-06	5.44e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	2.45e-06	5.39e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—obesity	2.45e-06	5.38e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TYK2—obesity	2.43e-06	5.35e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CD—obesity	2.42e-06	5.32e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RHOA—obesity	2.41e-06	5.31e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—obesity	2.41e-06	5.29e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CA—obesity	2.4e-06	5.27e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—obesity	2.39e-06	5.26e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOS3—obesity	2.39e-06	5.25e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3R1—obesity	2.39e-06	5.25e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TYK2—obesity	2.38e-06	5.23e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RHOA—obesity	2.36e-06	5.19e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK8—obesity	2.34e-06	5.14e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOS3—obesity	2.34e-06	5.14e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3R1—obesity	2.34e-06	5.14e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—obesity	2.33e-06	5.13e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TYK2—obesity	2.33e-06	5.12e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RHOA—obesity	2.31e-06	5.07e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3R1—obesity	2.29e-06	5.02e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOS3—obesity	2.29e-06	5.02e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	2.28e-06	5e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	2.23e-06	4.89e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CB—obesity	2.21e-06	4.85e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MTOR—obesity	2.21e-06	4.85e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CA—obesity	2.18e-06	4.78e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CB—obesity	2.16e-06	4.74e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MTOR—obesity	2.16e-06	4.74e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—obesity	2.14e-06	4.7e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MTOR—obesity	2.11e-06	4.64e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CB—obesity	2.11e-06	4.64e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—obesity	2.05e-06	4.5e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—obesity	2.02e-06	4.43e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—obesity	2e-06	4.4e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MYC—obesity	1.99e-06	4.37e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—obesity	1.98e-06	4.36e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—obesity	1.97e-06	4.33e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—obesity	1.96e-06	4.3e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—obesity	1.93e-06	4.24e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—obesity	1.92e-06	4.21e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—obesity	1.88e-06	4.12e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK8—obesity	1.86e-06	4.1e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—obesity	1.86e-06	4.09e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—obesity	1.83e-06	4.03e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK8—obesity	1.82e-06	4.01e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—obesity	1.82e-06	4e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK8—obesity	1.78e-06	3.92e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—obesity	1.78e-06	3.91e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—obesity	1.7e-06	3.75e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CA—obesity	1.69e-06	3.71e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—obesity	1.67e-06	3.66e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—obesity	1.63e-06	3.58e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MYC—obesity	1.58e-06	3.48e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—obesity	1.58e-06	3.47e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MYC—obesity	1.55e-06	3.4e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—obesity	1.55e-06	3.4e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MYC—obesity	1.52e-06	3.33e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—obesity	1.51e-06	3.32e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—obesity	1.5e-06	3.29e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—obesity	1.38e-06	3.03e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CA—obesity	1.34e-06	2.95e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CA—obesity	1.32e-06	2.89e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CA—obesity	1.29e-06	2.83e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—obesity	1.19e-06	2.62e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—obesity	1.16e-06	2.56e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—obesity	1.14e-06	2.5e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—obesity	1.1e-06	2.41e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—obesity	1.07e-06	2.36e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—obesity	1.05e-06	2.31e-05	CbGpPWpGaD
